Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Discoid and asteatotic eczema

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Arrange urgent assessment for rapidly spreading pain, fever, extensive blistering, erythroderma, severe lower-leg infection or a non-healing ulcerated plaque suspicious for malignancy.

Synopsis

Distinguish coin-shaped discoid eczema from fissured asteatotic eczema, exclude dermatophyte infection and venous disease, and treat dryness and inflammation without masking important mimics.

  • Discoid eczema forms very itchy round or oval plaques, often weepy and crusted early and dry or scaly later; it commonly mimics tinea corporis.
  • Asteatotic eczema produces superficial intersecting cracks on very dry skin, often shins of older adults in cold dry conditions.
  • On brown or black skin, active discoid plaques may appear dark brown, purple or paler and often leave persistent pigment change.
  • Scrape an untreated active scaly border when dermatophyte infection is plausible before escalating topical corticosteroid.
  • Reduce hot bathing and harsh soap, use a generous leave-on emollient and apply a site-appropriate topical corticosteroid to active plaques for a defined course.
  • A solitary plaque that remains indurated, ulcerated or treatment-resistant needs biopsy consideration rather than repeated empirical cream.
  • For Discoid and asteatotic eczema, document body sites, severity, sleep and function, recent treatment, infection features and what the patient can realistically apply each day.
  • In Discoid and asteatotic eczema, reassess the diagnosis when a well-used, correctly potent regimen fails rather than repeatedly intensifying treatment without examining adherence, exposure and mimics.

Key red flags

Systemic illness, painful expansion, purpura, widespread detachment, unilateral ulceration, palpable tumour, treatment-resistant annular disease or major lower-leg oedema requires broader investigation.

Malignancy departure

A solitary enlarging indurated plaque with bleeding, ulceration or failure of adequate therapy requires prompt specialist assessment.

Investigation priorities

01
Whole-skin, foot and nail examinationFirst step

Distinguish discoid and asteatotic patterns from psoriasis, venous disease and a fungal reservoir.

Management branches

Dry or asteatotic diseaseRestore barrier and reduce environmental loss

Craquelé fissures occur on dry skin without infection, tumour features or major venous disease.

  1. Shorten hot washing, stop harsh soap and apply a rich fragrance-free leave-on emollient at least twice daily and after washing.
  2. Use a site-appropriate topical corticosteroid on inflamed fissured areas for a defined short course while continuing emollient beyond clearance.
  3. Review heating, humidity, mobility and adequate product quantity and reassess if fissures become painful, wet or widespread.

Key medicines

Betamethasone valerate 0.1% creamApply a thin film to active trunk or limb plaques once or twice daily for up to four weeks, reducing frequency when inflammation is controlled.Avoid face, folds, infection, large areas and occlusion unless directed; review atrophy and systemic absorption and stop diagnostic masking when a plaque fails to respond.
Hydrocortisone 1% creamAdults apply thinly once or twice daily for no more than seven days under the product licence on appropriately selected mild or thin-site inflammation.Do not use on untreated infection, eyes or suspicious lesions; prolonged use and sensitising excipients can worsen diagnostic uncertainty.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Association of Dermatologists discoid eczemaMorphology, skin-tone variation, mimics and treatment.
  • NICE NG190 secondary bacterial infection of eczemaAntibiotic thresholds, choice, duration and reassessment.
  • Betamethasone valerate 0.1 percent cream SmPCPotent topical corticosteroid regimen and safeguards.
  • Hydrocortisone 1 percent cream SmPCMild topical corticosteroid regimen and restrictions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom